Study of Rucaparib versus Physician's Choice of Therapy for Patients with Metastatic Castration-resistant Prostate Cancer Associated with Homologous Recombination Deficiency (16238)
Study of Rucaparib versus Physician's Choice of Therapy for Patients with Metastatic Castration-resistant Prostate Cancer Associated with Homologous Recombination Deficiency (16238)
Trial Category:
Genitourinary
Phase
III
Contact(s)
Location(s)
Nebraska Cancer Specialists, Omaha, NE
